Clinical management outcomes of childhood glaucoma suspects

PLoS One. 2017 Sep 25;12(9):e0185546. doi: 10.1371/journal.pone.0185546. eCollection 2017.

Abstract

Purpose: To investigate the outcomes of childhood glaucoma suspects.

Design: Retrospective case series.

Methods: Records of childhood glaucoma suspects were identified using financial claims data; medical history, baseline biometric and exam findings were recorded. Conversion from suspect to glaucoma was determined based on the Childhood Glaucoma Research Network criteria. The study adheres to the tenets of the Declarations of Helsinki.

Results: 214 subjects were enrolled, with median age at initial presentation of 6.37 years (interquartertile range: Q1 = 2.46, Q3 = 8.90). 22 (10.2%) subjects developed glaucoma, 64 (29.9%) had ocular hypertension but no glaucoma, 9 (4.2%) had high-risk condition or syndrome without either ocular hypertension or glaucoma after a mean follow up of 39 +/- 34 months. Neither a family history of glaucoma nor patient gender was significantly different between the groups. 40.2% of subjects (86 of 214) had two or more episodes of intraocular pressure (IOP) > 21 mmHg, among which 25.6% (22 of 86) developed glaucoma after a mean duration of 32.8 +/- 33.5 months.

Conclusions: Up to 25% of children with 2 or more episodes of elevated IOP may develop glaucoma. In 50% of suspects who converted to glaucoma, elevated IOP was not present at the initial evaluation. There is no significant difference in gender, family history, or baseline central corneal thickness between suspects who developed glaucoma compared to the rest. While suspects who converted to glaucoma had higher average, maximum and minimum IOP measurements, there is no clear cutoff between the groups.

MeSH terms

  • Child
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Glaucoma / diagnosis
  • Glaucoma / physiopathology
  • Glaucoma / therapy
  • Humans
  • Infant
  • Intraocular Pressure
  • Male
  • Ocular Hypertension / diagnosis*
  • Ocular Hypertension / physiopathology
  • Ocular Hypertension / therapy
  • Time Factors
  • Treatment Outcome

Grants and funding

The authors received no specific funding for this work.